VALEMETOSTAT

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C26H34ClN3O4
Molecular Weight	488.019
Optical Activity	UNSPECIFIED
Defined Stereocenters	3 / 3
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN(C)[C@H]1CC[C@@H](CC1)[C@@]2(C)OC3=C(Cl)C=C(C(=O)NCC4=C(C)C=C(C)NC4=O)C(C)=C3O2

InChI

InChIKey=SSDRNUPMYCFXGM-UYPAYLBCSA-N

InChI=1S/C26H34ClN3O4/c1-14-11-15(2)29-25(32)20(14)13-28-24(31)19-12-21(27)23-22(16(19)3)33-26(4,34-23)17-7-9-18(10-8-17)30(5)6/h11-12,17-18H,7-10,13H2,1-6H3,(H,28,31)(H,29,32)/t17-,18-,26-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C26H34ClN3O4
Molecular Weight	488.019
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	3 / 3
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

C_max

Value	Dose	Co-administered	Analyte	Population
1500 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/37565616/	200 mg 1 times / day multiple, oral dose: 200 mg route of administration: Oral experiment type: MULTIPLE co-administered:		VALEMETOSTAT plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: HIGH-FAT
2230 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36150143/	200 mg single, oral dose: 200 mg route of administration: Oral experiment type: SINGLE co-administered:		VALEMETOSTAT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED

AUC

Value	Dose	Co-administered	Analyte	Population
10800 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/37565616/	200 mg 1 times / day multiple, oral dose: 200 mg route of administration: Oral experiment type: MULTIPLE co-administered:		VALEMETOSTAT plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: HIGH-FAT
18100 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36150143/	200 mg single, oral dose: 200 mg route of administration: Oral experiment type: SINGLE co-administered:		VALEMETOSTAT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED

T_1/2

Value	Dose	Co-administered	Analyte	Population
20.4 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/37565616/	200 mg 1 times / day multiple, oral dose: 200 mg route of administration: Oral experiment type: MULTIPLE co-administered:		VALEMETOSTAT plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: HIGH-FAT
9.46 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/36150143/	200 mg single, oral dose: 200 mg route of administration: Oral experiment type: SINGLE co-administered:		VALEMETOSTAT plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED

F_unbound

Value	Dose	Co-administered	Analyte	Population
10% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/37565616/	200 mg 1 times / day multiple, oral dose: 200 mg route of administration: Oral experiment type: MULTIPLE co-administered:		VALEMETOSTAT plasma	Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: HIGH-FAT

Substance Class	Chemical Created by `admin` on `Mon Mar 31 22:45:45 GMT 2025` Edited by `admin` on `Mon Mar 31 22:45:45 GMT 2025`
Record UNII	60RD0234VE
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

VALEMETOSTAT

Official Name

English

EZH1/2 INHIBITOR DS-3201

Preferred Name

English

valemetostat [INN]

Common Name

English

Valemetostat [WHO-DD]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C471